Biological E's Corbevax gets nod for phase 2/3 trials on those aged 5-18

India's drug regulator has granted permission to Hyderabad-based Biological E Limited to conduct phase 2/3 clinical trials of its COVID-19 vaccine on children aged between 5 and 18 years with certain conditions , PTI has reported.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/38Bs8Dw
via IFTTT